Shattil S J, Cines D B, Schreiber A D
J Clin Invest. 1978 Mar;61(3):582-9. doi: 10.1172/JCI108969.
Complement appears to be involved in the destruction of platelets in certain clinical disorders, such as quinidine purpura and post-transfusion purpura. In both disorders, the classical complement sequence is activated by antigen-antibody complexes. It has been suggested that the terminal components of the complement sequence insert into the hydrophobic core of cell surface membranes and that this process leads to cell lysis. Fluidity is a fundamental property of lipids within the membrane's hydrophobic core. To examine the interaction of complement with membranes, we investigated the effect of complement activation on the fluidity of human platelet membranes. Complement was fixed to platelets using a post-transfusion purpura antibody, and membrane lipid fluidity was assessed in terms of fluorescence anisotropy using two fluorescent probes, 1,6-diphenyl-1,3,5-hexatriene and 9-(12-anthroyl) stearic acid. Microviscosity, expressed in poise, was derived from the fluorescence anisotropy of 1,6-diphenyl-1,3,5-hexatriene.Post-transfusion purpura antibody plus complement made platelet membranes more fluid as evidenced by a 21% decrease in anisotropy and a 35% decrease in microviscosity of platelets at 37 degrees C, and this was associated with platelet lysis ((51)Cr release). Complement damage to platelets was accompanied by a 10-15% increase in DeltaE, the fusion activation energy for microviscosity, indicating that complement not only decreased membrane microviscosity but also made membrane lipids less ordered. These changes were consistent and rapid, with platelet lysis and the reduction in microviscosity being half-maximal by 6 min. They were prevented by inactivation of complement with heat or with EDTA, and they were not observed when C5-deficient plasma was used as the complement source. Qualitatively similar changes in platelet membrane fluidity were observed when complement was fixed to platelets by a quinidine-dependent anti-platelet antibody rather than by post-transfusion purpura antibody. Post-transfusion purpura antibody plus complement also decreased the microviscosity of isolated platelet membranes. Moreover, the lipids extracted from platelets lysed by complement had a 22% decrease in microviscosity (P < 0.01), with no associated changes in the amount of cholesterol relative to phospholipid or in the amounts of the various phospholipids. These studies demonstrate that lipids within the hydrophobic core of platelet membranes damaged by complement become more fluid, and this is associated with platelet lysis. These findings are consistent with the concept that the insertion of the terminal complement components into the platelet membrane bilayer perturbs lipid-lipid interactions within the membrane's hydrophobic core.
补体似乎参与了某些临床疾病中血小板的破坏,如奎尼丁紫癜和输血后紫癜。在这两种疾病中,经典补体途径被抗原-抗体复合物激活。有人提出,补体途径的末端成分插入细胞表面膜的疏水核心,这一过程导致细胞裂解。流动性是膜疏水核心内脂质的基本特性。为了研究补体与膜的相互作用,我们研究了补体激活对人血小板膜流动性的影响。使用输血后紫癜抗体将补体固定在血小板上,并用两种荧光探针1,6-二苯基-1,3,5-己三烯和9-(12-蒽酰基)硬脂酸通过荧光偏振来评估膜脂质流动性。以泊表示的微粘度由1,6-二苯基-1,3,5-己三烯的荧光偏振得出。输血后紫癜抗体加补体使血小板膜流动性增加,在37℃时血小板的偏振度降低21%,微粘度降低35%,这与血小板裂解((51)Cr释放)相关。补体对血小板的损伤伴随着微粘度融合活化能DeltaE增加10 - 15%,表明补体不仅降低了膜微粘度,还使膜脂质的有序性降低。这些变化是一致且迅速的,血小板裂解和微粘度降低在6分钟时达到最大值的一半。用加热或EDTA使补体失活可阻止这些变化,当使用C5缺陷血浆作为补体来源时未观察到这些变化。当用奎尼丁依赖性抗血小板抗体而非输血后紫癜抗体将补体固定在血小板上时,观察到血小板膜流动性有定性相似的变化。输血后紫癜抗体加补体也降低了分离的血小板膜的微粘度。此外,从被补体裂解的血小板中提取的脂质微粘度降低了22%(P < 0.01),相对于磷脂的胆固醇含量或各种磷脂的含量没有相关变化。这些研究表明,被补体损伤的血小板膜疏水核心内的脂质变得更具流动性,这与血小板裂解相关。这些发现与末端补体成分插入血小板膜双层扰乱膜疏水核心内脂质-脂质相互作用的概念一致。